High Quality and Affordable
>주요서비스>Peptide
Synthesis>Modified Peptide
| Modification Type |
|---|
| {H-},Free amino group |
| {Ac},Acetylation |
| {Br-Ac},Bromoacetyl |
| {Bromopropionyl} |
| {Cl-Ac},Chloroacetyl |
| {Fmoc},9-Fluorenylmethyloxycarbonyl |
| {Z},{CBZ},Benzyloxycarbonyl |
| {Bz},benzoyl |
| {4-F-Bz} |
| {Cl-Ac},Chloroacetyl |
| {Boc},tertbutoxycarbonyl |
| {Suc},succinyl |
| {MeO-Suc} |
| Sebacic acid |
| {Allyl},allyl |
| {Acryl},acryl |
| {Alloc},allyloxycarbonyl |
| {For}, Formylation |
| {HPP},4-Hydroxyphenylpropionic acid |
| {pGlu},{Pyr},Pyroglutamyl |
| {LA}, Lipoic acid |
| {Mpa},3-Mercaptopropyl |
| {6-mercaptohexanoic acid} |
| {Mal}, Maleimide, Maleoyl-b-Ala |
| Mal-Acp |
| {MTX}, Methotrexate |
| {PEG1900}, PEG1900-NH- |
| {NH2-PEG2000}, NH2-PEG2000-NH-Suc- |
| {mPEG2000}, MeO-PEG2000-NH- |
| {mPEG3000}, MeO-PEG3000-NH- |
| {mPEG5000}, MeO-PEG5000-NH- |
| {SATA}, S-acetylthioacetate |
| {SATP}, S-acetylthiopropionate |
| {Cholesteryl-}, Cholesteryl chloroformate |
| {Glucose-} |
| {Fructose-} |
| Pyridin-1-yl-Acetyl- |
| 4-Dimethylamino-Pyridin-1-yl- |
| Adamantanecarbonyl- |
| Phenylacetic acid |
| 4-Biphenyl sulfonyl- |
| Nitrilotriacetyl- |
| N-Propargylglycine- |
| HYNIC- |
| Morpholine-4-carbonyl- |
| 5-amino-2-nitrobenzonic acid |
| Azido-PEG4- |
| GAC- |
| {Aoa} |
| N3-Gly |
| N3-Acp |
| Modification Type |
|---|
| {But}, Butyric acid C4 |
| {Iba}, isobutyric acid C4 |
| {Hex}, Hexanoic acid C6 |
| {Oct}, Octanoic acid C8 |
| {F-Oct}, Perfluoro Octanoic acid F15C8 |
| {Dec}, Decanoic acid C10 |
| {F-Dec}, Perfluoro Decanoic acid F19C10 |
| {Lau}, Lauric acid C12 |
| {F-Lau}, Perfluoro Lauric acid F23C12 |
| {Myr}, Myristic acid C14 |
| {F-Myr}, Perfluoro Myristic acid F27C14 |
| {Pal}, Palmitic acid C16 |
| {Ste}, Stearic acid C18 |
| {Ste}, Stearic acid C18 |
| Oleic Acid- |
| {Pam3C}, Tripalmitoyl cysteine, {Pal-Cys(Pal)2-} |
| Modification Type |
|---|
| {-OH}, free acid group |
| {NH2}, Amidation |
| {-CHO}, peptide aldehydes |
| {-ol}, alcohol peptide |
| {CMK}, chloromethylketone |
| {FMK}, Fluoromethylketone |
| {Cya}, Cysteamide |
| {pNA},p-nitroaniline |
| {-ONP}, para-nitrophenol |
| {AMC},7-Amino-4-methylcoumarin |
| {AFC} |
| -OMe (C-terminal) |
| -OEt (C-terminal) |
| -OBzl (C-terminal) |
| -OtBu (C-terminal) |
| {-OSu}, hydroxysucinimide ester |
| -NHMe (C-terminal) |
| -NHEt (C-terminal) |
| -NHisopen (C-terminal) |
| -NH(CH2)6 (C-terminal) |
| -NHPh (C-terminal) |
| {NHEt(O)EtNH-Fmoc}, 2,2'-Oxydi Ethanamine-Fmoc |
| {NHEt(EtNH-Myr)2} |
| -NH(OMe)Me (C-terminal) |
| -TBzl (C-terminal) |
| -NHNH2 (C-terminal) |
| -ED (C-terminal), -NH-CH2CH2-NH2 |
| -BD (C-terminal), -NH-CH2CH2CH2CH2-NH2 |
| -Pyrenemethylamine |
| chloro-4-hydroxyanilide |
| 4-amino-2-Chlorophenol |
| -octyl ester |
| -ED-Fmoc |
| Modification Type |
|---|
| {D-Ala} |
| {D-Arg} |
| {D-Asp} |
| {D-Asn} |
| {D-Cys} |
| {D-Glu} |
| {D-Gln} |
| {D-Glu} |
| {D-His} |
| {D-Allo-Ile} |
| {D-Leu} |
| {D-Lys} |
| {D-Met} |
| {D-Pro} |
| {D-Phe} |
| {D-Ser} |
| {D-Tyr} |
| {D-Thr} |
| {D-Trp} |
| {D-Val} |
| Modification Type |
|---|
| {Beta-Asp} |
| {D-Beta-Asp} |
| {Gamma-Glu} |
| {D-Gamma-Glu} |
| {Cys(Cam)} |
| {Cys(Acm)} |
| {Cys(tBu)} |
| {Met(O)} |
| {D-Met(O)} |
| {Met(O)2} |
| {D-Met(O)2} |
| {Lys(Ac)} |
| {Ac-Lys} |
| {Lys(Dde)} |
| {Tle} |
| {Ser(octanoic acid)} |
| {D-Ser(octanoic acid)} |
| {Aib} |
| {Abu} |
| {D-Abu} |
| {Hyp} |
| {Phg} |
| {D-Phg} |
| {Nva} |
| {D-Nva} |
| {Nle} |
| {D-Nle} |
| {Cit} |
| {D-Cit} |
| {Orn} |
| {D-Orn} |
| {Pen} |
| {D-Pen} |
| {Cpg}, cyclopentylglycine |
| {Cha} |
| {D-Cha} |
| {Chg} |
| {D-Chg} |
| {Dab} |
| {Dap} |
| {Pra} |
| {D-Pra} |
| {Gly(allyl)} |
| {D-Gly(allyl)} |
| {D-1-Nal} |
| {L-1-Nal} |
| {D-2-Nal} |
| {L-2-Nal} |
| {D-2-Pal} |
| {L-2-Pal} |
| {D-3-Pal} |
| {L-3-Pal} |
| {D-4-Pal} |
| {L-4-Pal} |
| {Cys(pMeBzl)} |
| {Cys(pMeOBzl)} |
| {Oic} |
| {Tic} |
| {Cys(Bzl)} |
| {Epsilon-Lys} |
| {D-Epsilon-Lys} |
| {5-ASA} |
| {Bpa} |
| {Pip} |
| {Nip} |
| {2-Aze} |
| {3-Aze} |
| [Psi(CH2NH)] |
| [CS-NH] |
| {Se-Met} |
| {Se-Cys} |
| {DOPA} |
| {isoGln} |
| {D-isoGln} |
| Cys(Mal-PEG2000) |
| {Ser(O-b-D-Glc)} |
| {Thr(O-b-D-Glc)} |
| {Tyr(O-b-D-Glc)} |
| {Rink Linker} |
| {Thr(OAc)} |
| {Delta-Orn} |
| {5,5-Dime-Pro} |
| {Gla} |
| {Kep} |
| {X}, 20 Kinds mixture amino acids |
| {X-deCys} |
| {G/A/S/V/L/D/K/M/F/Y} |
| {A/P/T/N/Q/E/H/R/W} |
| {K(75)X(25)} |
| {R(25)K(25)X(50)} |
| {E(25)D(25)X(50)} |
| {K(25)Q(25)X(50)} |
| {E(25)T(25)X(50)} |
| Modification Type |
|---|
| Biotin (N-Terminal) |
| EDBiotin (C terminus) |
| Lys(Biotin) (middle) |
| Lys(Biotin) (C temrinus) |
| Lys(Biotin) (N terminus) |
| Biotin-LC (N-Terminal) |
| Lys(LC-Biotin) (middle) |
| Lys(LC-Biotin) (C terminus) |
| Orn(Bio) |
| -NH-PEG3-Bio |
| FITC (N-Terminal) |
| EDFITC (C temrinus) |
| Lys(FITC) (middle) |
| Lys(FITC) (C temrinus) |
| Lys(FITC) (N terminus) |
| FITC-LC (N-Terminal) |
| 5-FAM (N-Terminal) |
| ED5-FAM (C temrinus) |
| Lys(5-FAM) (middle) |
| Lys(5,6-FAM) |
| Lys(5-FAM) (C temrinus) |
| Lys(5-FAM) (N-Terminus) |
| 5-FAM-LC (N-Terminal) |
| Dansyl (N-Terminal) |
| EDDansyl (C temrinus) |
| Lys(Dansyl) (middle) |
| Lys(Dansyl) (C temrinus) |
| Lys(Dansyl) (N-Terminus) |
| Dansyl-LC (N-Terminal) |
| TAMRA (N-Terminal) |
| 5(6)-TAMTA- |
| EDTAMRA (C temrinus) |
| Lys(TAMRA) (middle) |
| Lys(TAMRA) (C temrinus) |
| Lys(TAMRA) (N-terminus) |
| TAMRA-LC (N-Terminal) |
| Lys(Dnp) (middle) |
| D-Lys(Dnp) (middle) |
| Dab(Dnp) (middle) |
| Dap(Dnp) (middle) |
| EDDnp (C terminus) |
| MCA (N-Terminal) |
| Lys(MCA) (middle) |
| Lys(MCA) (C temrinus) |
| Lys(MCA) (N-terminus) |
| 3-Indolylacetic acid (N-Terminal) |
| Cys(Npys) (N-terminus) |
| PyBA- (N-Terminal), 1-pyrenebutyric acid |
| Lys(PyBA) |
| Fa- (N-Terminal), 3-[2-2furyl]acrylic acid |
| Rhodamine B- (N-Terminal) |
| D-Luciferin (N-terminus) |
| Cy3- (N-Terminal) |
| NBD |
| Modification Type |
|---|
| {D-2-Cl-Phe} |
| {L-2-Cl-Phe} |
| {D-3-Cl-Phe} |
| {L-3-Cl-Phe} |
| {D-4-Cl-Phe} |
| {L-4-Cl-Phe} |
| {D-3,4-DiCl-Phe} |
| {L-3,4-DiCl-Phe} |
| {D-4-Br-Phe} |
| {L-4-Br-Phe} |
| {D-3-F-Phe} |
| {L-3-F-Phe} |
| {D-4-F-Phe} |
| {L-4-F-Phe} |
| {D-4-NO2-Phe} |
| {L-4-NO2-Phe} |
| {D-4-I-Phe} |
| {L-4-I-Phe} |
| {D-3-CN-Phe} |
| {L-3-CN-Phe} |
| {D-4-CN-Phe} |
| {L-4-CN-Phe} |
| {D-2-Me-Phe} |
| {L-2-Me-Phe} |
| {D-4-Me-Phe} |
| {L-4-Me-Phe} |
| {D-4-NH2-Phe} |
| {L-4-NH2-Phe} |
| {D-3-Cl-Tyr} |
| {L-3-Cl-Tyr} |
| {D-3,5-DiCl-Tyr} |
| {L-3,5-DiCl-Tyr} |
| {D-3,5-DiBr-Tyr} |
| {L-3,5-DiBr-Tyr} |
| {D-3-I-Tyr} |
| {L-3-I-Tyr} |
| {D-3,5-DiI-Tyr} |
| {L-3,5-DiI-Tyr} |
| {D-3-NO2-Tyr} |
| {L-3-NO2-Tyr} |
| {D-3,5-DiNO2-Tyr} |
| {L-3,5-DiNO2-Tyr} |
| {L-3-F-Tyr} |
| Modification Type |
|---|
| {Har}, HomoArg |
| {Hcy}, HomoCys |
| {HPh}, HomoPhe |
| {D-HPh}, D-HomoPhe |
| {Hse}, HomoSer |
| {D-Hse}, D-HomoSer |
| {HomoCit}, HomoCit |
| {D-HomoCit}, D-HomoCit |
| {HomoLeu}, HomoLeu |
| {HomoPro}, HomoPro |
| {D-HomoPro}, D-HomoPro |
| {beta-HomoIle}, beta-HomoIle |
| {beta-HomoLeu}, beta-HomoLeu |
| {beta-HomoMet}, beta-HomoMet |
| {beta-HomoPro}, beta-HomoPro |
| {beta-HomoVal}, beta-HomoVal |
| {beta-HomoAsp}, beta-HomoAsp |
| {beta-HomoAsn}, beta-HomoAsn |
| {beta-HomoGlu}, beta-HomoGlu |
| {beta-HomoGln}, beta-HomoGln |
| {beta-HomoSer}, beta-HomoSer |
| {beta-HomoThr}, beta-HomoThr |
| {beta-HomoTrp}, beta-HomoTrp |
| {beta-HomoTyr}, beta-HomoTyr |
| {Azidohomoalanine}, Azidohomoalanine |
| {beta-HomoAla}, beta-HomoAla |
| {beta-HomoPhe}, beta-HomoPhe |
| {beta-HomoLys}, beta-HomoLys |
| Modification Type |
|---|
| Abz |
| Tyr (3-NO2) |
| Glu(EDANS)-NH2 |
| DABCYL |
| Lys(DABCYL) |
| Lys(Abz) |
| Modification Type |
|---|
| Symmetric 2 Branches (Pure) |
| Orn Symmetric 2 Branches (Pure) |
| Symmetric 4 Branches (Crude) |
| Orn Symmetric 4 Branches (Crude) |
| Symmetric 8 Branches (Crude) |
| Orn Symmetric 8 Branches (Crude) |
| Glu 2 Branches (N temrinus) |
| Glycerol 3 branches (C terminus) |
| Lys(Ala) |
| Lys(Arg) |
| Lys(Asp) |
| Lys(Cys) |
| Lys(Glu) |
| Lys(Leu) |
| Lys(Met)- |
| Lys(Phe)- |
| Lys(Val) |
| Lys(Beta-Asp) |
| Lys(Gama-Glu) |
| Lys(Cholesteryl) |
| Lys(LA) |
| Lys(MTX) |
| Lys(Maleimide) |
| Lys(Mpa) |
| Lys(Pra) |
| Lys(Suc) |
| Lys(pGlu) |
| Lys(For) |
| Lys(Ma) |
| Lys(Pal) |
| Lys(Gama-Glu-Pal) |
| Lys(4-HBA) |
| Lys(Acrylic) |
| Lys(Alkine) |
| {Lys(Alloc)} |
| {Lys(Butanoyl)} |
| Lys(cyclopropanecarboxyl) |
| Lys(Crotonyl) |
| {Lys(3,5-diiodo-4-hydroxybenzoyl)} |
| Lys(HMP) |
| {Lys(Ahx-Diazirine)} |
| {Lys(propargyl)} |
| {Lys(propionyl)} |
| Lys(2-hydroxyisobutyryl) |
| Lys(methylmalony) |
| Lys(HYNIC) |
| BSA-Peptide Cys |
| KLH-Peptide Cys |
| OVA-Peptide Cys |
| Modification Type |
|---|
| {Gly}, 2 atoms |
| {Beta-Ala}, 3 atoms |
| {GABA}, 4 atoms |
| {Ava}, 5 atoms |
| {Ahx}, 6 atoms |
| {8-Aoc} |
| {AEA},aminoethoxyacetic acid |
| {Mini-PEG}, AEEA 9 atoms |
| {Mini-PEG2}, AEEEP 13 atoms |
| {Mini-PEG3},AEEEEP 16 atoms |
| {PEG4} |
| {PEG6} |
| {PEG8} |
| {PEG11} |
| {PEG-12} |
| {Ado} |
| {ANP Linker} |
| Modification Type |
|---|
| {Arg(Me)} |
| {ADMA},{Arg(Me)2} asymmetrical |
| {SDMA},{Arg(Me)2} symmetrical |
| {Tyr(Me)} |
| {Thr(Me)} |
| {Ser(Me)} |
| {Cys(Me)}, SMC |
| {Lys(Me)} |
| {Lys(Me2)} |
| {Lys(Me3)} |
| {L-2-Me-Trp} |
| {D-2-Me-Trp} |
| {Tyr(Et)} |
| {D-Tyr(Et)} |
| {Orn(Me)3} |
| {L-1-Me-Trp} |
| Modification Type |
|---|
| {N-Me-Ala} |
| {N-Me-Phe} |
| {N-Me-Leu} |
| {N-Me-Ile} |
| {N-Me-Val} |
| {N-Me-Met} |
| {N-Me-Nle} |
| {N-Me-Nva} |
| {N-Me-Gly}, Sar |
| {N-Me-Ser} |
| {N-Me-Tyr} |
| {N-Me-Thr} |
| {N-Me-Asp} |
| {N-Me-Glu} |
| Modification Type |
|---|
| Mono Disulfide bridge |
| Double Disulfide bridge |
| Triple Disulfide bridge |
| Random Triple Disulfide bridge |
| Same Seq. Inter-Disulfide bridge |
| Different Inter-Disulfide bridge |
| Amide cyclic (end) |
| Amide cyclic (Side chain) |
| Orn side chain Amide cyclic |
| Thioester cyclic |
| Lactone cyclic |
| Modification Type |
|---|
| {pSer} |
| {pTyr} |
| {pThr} |
| {D-pSer} |
| {D-pTyr} |
| {D-pThr} |
| Di-sites in sequence |
| Tri-sites in sequence |
| 4-sites in sequence |
| 5-sites in sequence |
* resource from BBI website
Quick order
